Literature DB >> 32863446

Phospholipidation of TLR7/8-active imidazoquinolines using a tandem phosphoramidite method.

Hélène G Bazin1, Laura S Bess1, Mark T Livesay1, Sandra C Mwakwari1, David A Johnson1.   

Abstract

A high-yielding and scalable phosphoramidite procedure was developed for the phospholipidation of TLR7/8-active imidazoquinolines. This method involves the reaction of a 1,2-diacyl- or dialkyl-sn-glycerol or 3-chlolesterylalkanol with 2-cyanoethyl N,N,N',N'-tetraisopropylphosphordiamidite in the presence of 1H-tetrazole followed by treatment of the resulting N,N'-diisopropylphosphoramidite lipid in situ with 1-imidazoquinolinylalkanols. The resulting phosphite can be purified or directly oxidized with t-butyl hydroperoxide. The cyanoethyl protecting group is then removed with triethylamine and the phospholipidated imidazoquinoline products isolated in good yield and purity by simple filtration.

Entities:  

Keywords:  TLR7/8; imidazoquinoline; phospholipidation; phosphoramidite

Year:  2016        PMID: 32863446      PMCID: PMC7451945          DOI: 10.1016/j.tetlet.2016.03.091

Source DB:  PubMed          Journal:  Tetrahedron Lett        ISSN: 0040-4039            Impact factor:   2.415


  13 in total

1.  Chemical synthesis and molecular recognition of phosphatase-resistant analogues of phosphatidylinositol-3-phosphate.

Authors:  Yong Xu; Stephanie A Lee; Tatiana G Kutateladze; Diego Sbrissa; Assia Shisheva; Glenn D Prestwich
Journal:  J Am Chem Soc       Date:  2006-01-25       Impact factor: 15.419

2.  Efficient activation of nucleoside phosphoramidites with 4,5-dicyanoimidazole during oligonucleotide synthesis.

Authors:  C Vargeese; J Carter; J Yegge; S Krivjansky; A Settle; E Kropp; K Peterson; W Pieken
Journal:  Nucleic Acids Res       Date:  1998-02-15       Impact factor: 16.971

Review 3.  Nucleolipids: natural occurrence, synthesis, molecular recognition, and supramolecular assemblies as potential precursors of life and bioorganic materials.

Authors:  Helmut Rosemeyer
Journal:  Chem Biodivers       Date:  2005-08       Impact factor: 2.408

4.  Synthesis and structure-activity-relationships of 1H-imidazo[4,5-c]quinolines that induce interferon production.

Authors:  John F Gerster; Kyle J Lindstrom; Richard L Miller; Mark A Tomai; Woubalem Birmachu; Shannon N Bomersine; Shiela J Gibson; Linda M Imbertson; Joel R Jacobson; Roy T Knafla; Peter V Maye; Nickolas Nikolaides; Folakemi Y Oneyemi; Gwen J Parkhurst; Sharon E Pecore; Michael J Reiter; Lisa S Scribner; Tracy L Testerman; Natalie J Thompson; Tammy L Wagner; Charles E Weeks; Jean-Denis Andre; Daniel Lagain; Yvon Bastard; Michel Lupu
Journal:  J Med Chem       Date:  2005-05-19       Impact factor: 7.446

5.  Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway.

Authors:  Hiroaki Hemmi; Tsuneyasu Kaisho; Osamu Takeuchi; Shintaro Sato; Hideki Sanjo; Katsuaki Hoshino; Takao Horiuchi; Hideyuki Tomizawa; Kiyoshi Takeda; Shizuo Akira
Journal:  Nat Immunol       Date:  2002-01-22       Impact factor: 25.606

6.  Activation of anti-hepatitis C virus responses via Toll-like receptor 7.

Authors:  Jongdae Lee; Christina C N Wu; Ki Jeong Lee; Tsung-Hsien Chuang; Kyoko Katakura; Yu-Tsueng Liu; Michael Chan; Rommel Tawatao; Michelle Chung; Carol Shen; Howard B Cottam; Michael M C Lai; Eyal Raz; Dennis A Carson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-30       Impact factor: 11.205

7.  Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: activation of Toll-like receptor 7.

Authors:  Jongdae Lee; Tsung-Hsien Chuang; Vanessa Redecke; Liping She; Paula M Pitha; Dennis A Carson; Eyal Raz; Howard B Cottam
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-08       Impact factor: 11.205

8.  The Toll-like receptor 7 (TLR7)-specific stimulus loxoribine uncovers a strong relationship within the TLR7, 8 and 9 subfamily.

Authors:  Florian Heil; Parviz Ahmad-Nejad; Hiroaki Hemmi; Hubertus Hochrein; Franziska Ampenberger; Tanja Gellert; Harald Dietrich; Grayson Lipford; Kiyoshi Takeda; Shizuo Akira; Hermann Wagner; Stefan Bauer
Journal:  Eur J Immunol       Date:  2003-11       Impact factor: 5.532

9.  Synthesis and immunological characterization of toll-like receptor 7 agonistic conjugates.

Authors:  Michael Chan; Tomoko Hayashi; Crystal S Kuy; Christine S Gray; Christina C N Wu; Maripat Corr; Wolfgang Wrasidlo; Howard B Cottam; Dennis A Carson
Journal:  Bioconjug Chem       Date:  2009-06       Impact factor: 4.774

10.  3-(N-tert-butylcarboxamido)-1-propyl and 4-oxopentyl groups for phosphate/thiophosphate protection in oligodeoxyribonucleotide synthesis.

Authors:  Andrzej Wilk; Marcin K Chmielewski; Andrzej Grajkowski; Serge L Beaucage; Lawrence R Phillips
Journal:  Curr Protoc Nucleic Acid Chem       Date:  2003-02
View more
  2 in total

1.  Development of a TLR7/8 agonist adjuvant formulation to overcome early life hyporesponsiveness to DTaP vaccination.

Authors:  David J Dowling; Soumik Barman; Alyson J Smith; Francesco Borriello; Danielle Chaney; Spencer E Brightman; Gandolina Melhem; Byron Brook; Manisha Menon; Dheeraj Soni; Simone Schüller; Karthik Siram; Etsuro Nanishi; Hélène G Bazin; David J Burkhart; Ofer Levy; Jay T Evans
Journal:  Sci Rep       Date:  2022-10-18       Impact factor: 4.996

2.  Using Dual Toll-like Receptor Agonism to Drive Th1-Biased Response in a Squalene- and α-Tocopherol-Containing Emulsion for a More Effective SARS-CoV-2 Vaccine.

Authors:  Kristopher K Short; Stephanie K Lathrop; Clara J Davison; Haley A Partlow; Johnathan A Kaiser; Rebekah D Tee; Elizabeth B Lorentz; Jay T Evans; David J Burkhart
Journal:  Pharmaceutics       Date:  2022-07-12       Impact factor: 6.525

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.